CRIO Announces Partnership with Pluto Health
CRIO in partnership with Pluto Health has announced the development of an integration between clinical care and clinical research. CRIO's Medical Records API delivers electronic medical records and other health histories, alongside clinical care coordination. The Pluto Health team then provides ongoing health maintenance support for potential participants. All this information is shared with patients, and with patient consent, can be shared with their clinicians and directly to principal investigators (PIs) at clinical research sites.
CRIO's partnership with Pluto Health leverages the recent trends towards patient centricity within clinical trials, focusing on addressing the patient journey in its entirey. It delivers a method to support patients' care pathways through clinical coordination, while streamlining PI workflow, and enabling patient control over their health information.
This approach goes beyond PIs access to EMR data. The approach reviews and reconciles health status before entry into the EDC, and offers care coordination tools to advance patient care alongside clinical research operations. Once review and reconciliation are completed, the source records are populated in the EDC and remote monitors can view the underlying sanitized medical records with principal investigator annotations, along with the source records. This level of transparency enhances sponsor oversight of quality and patient safety.
Reference
CRIO Announces Partnership with Pluto Health to Expand and Accelerate Clinical Trial Access. (2023, July 19). Cision PR Newsire.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
